TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T35264	Purinergic receptor P2Y12	D02LMZ	ATPase	Phase 2	5957	C10H16N5O13P3	507.18	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N	IC50 = 251188.64 nM	Non binder
T35264	Purinergic receptor P2Y2	D02LMZ	ATPase	Phase 2	5957	C10H16N5O13P3	507.18	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N	EC50 > 300000 nM	Non binder
T35264	Purinergic receptor P2Y12	B09FQD	(4-Nitrobenzotriazol-1-yl)-phenylmethanone	Investigative	137650737	C13H8N4O3	268.23	C1=CC=C(C=C1)C(=O)N2C3=C(C(=CC=C3)[N+](=O)[O-])N=N2	IC50 = 650000 nM	Non binder
T35264	Purinergic receptor P2Y12	B0H8GU	1-(4-Methylphenyl)sulfonyl-4-nitrobenzotriazole	Investigative	137644622	C13H10N4O4S	318.31	CC1=CC=C(C=C1)S(=O)(=O)N2C3=C(C(=CC=C3)[N+](=O)[O-])N=N2	IC50 = 860000 nM	Non binder
T35264	Purinergic receptor P2Y12	B1H6AG	2-Butyl-4-nitrobenzotriazole	Investigative	137651269	C10H12N4O2	220.23	CCCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 1070000 nM	Non binder
T35264	Purinergic receptor P2Y14	B1RUX8	Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-alpha-D-Glucose	Investigative	448923	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)F)O)O	EC50 = 2500000 nM	Non binder
T35264	Purinergic receptor P2Y12	B1UIW7	2-Ethyl-4-nitrobenzotriazole	Investigative	137649986	C8H8N4O2	192.17	CCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 1620000 nM	Non binder
T35264	Purinergic receptor P2Y2	B2HKE1	Chembl4209172	Investigative	121487678	C15H27N2O15P3	568.3	CCCCCCOC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O	EC50 = 489300 nM	Non binder
T35264	Purinergic receptor P2Y12	B2U0AQ	4-Nitro-1H-1,2,3-benzotriazole	Investigative	80533	C6H4N4O2	164.12	C1=CC2=NNN=C2C(=C1)[N+](=O)[O-]	IC50 = 2060000 nM	Non binder
T35264	Purinergic receptor P2Y12	B3ISY7	2-Benzyl-4-nitrobenzotriazole	Investigative	51032397	C13H10N4O2	254.24	C1=CC=C(C=C1)CN2N=C3C=CC=C(C3=N2)[N+](=O)[O-]	IC50 = 820000 nM	Non binder
T35264	Purinergic receptor P2Y12	B48GPW	4-Nitro-2-pentylbenzotriazole	Investigative	137639442	C11H14N4O2	234.25	CCCCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 1020000 nM	Non binder
T35264	Purinergic receptor P2Y14	B4CJ9M	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	Investigative	448872	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)F)O)O)O)O	EC50 = 567000 nM	Non binder
T35264	Purinergic receptor P2Y12	B7NQ3E	4-Nitro-2-propylbenzotriazole	Investigative	137635690	C9H10N4O2	206.2	CCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 1320000 nM	Non binder
T35264	Purinergic receptor P2Y12	B85TQO	4-Nitro-1-propylbenzotriazole	Investigative	85909513	C9H10N4O2	206.2	CCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1300000 nM	Non binder
T35264	Purinergic receptor P2Y12	B8IGN1	4-Nitro-1-octylbenzotriazole	Investigative	137631406	C14H20N4O2	276.33	CCCCCCCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 940000 nM	Non binder
T35264	Purinergic receptor P2Y14	BA5CZ6	Cyclohexyl [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate	Investigative	44627698	C15H24N2O12P2	486.3	C1CCC(CC1)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O	EC50 = 5160000 nM	Non binder
T35264	Purinergic receptor P2Y12	BC13ZD	2-(3-Chloropropyl)-4-nitrobenzotriazole	Investigative	137634506	C9H9ClN4O2	240.64	C1=CC2=NN(N=C2C(=C1)[N+](=O)[O-])CCCCl	IC50 = 1260000 nM	Non binder
T35264	Purinergic receptor P2Y12	BC3H4K	1-Benzyl-4-nitrobenzotriazole	Investigative	20300396	C13H10N4O2	254.24	C1=CC=C(C=C1)CN2C3=C(C(=CC=C3)[N+](=O)[O-])N=N2	IC50 = 810000 nM	Non binder
T35264	Purinergic receptor P2Y12	BDIF98	2-Methyl-4-nitrobenzotriazole	Investigative	4603056	C7H6N4O2	178.15	CN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 1960000 nM	Non binder
T35264	Purinergic receptor P2Y14	BG5IO3	Uridine 5'-diphosphoric acid beta-(3-fluoro-3-deoxy-alpha-D-glucopyranosyl) ester	Investigative	24858471	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)F)O)O)O	EC50 = 361000 nM	Non binder
T35264	Purinergic receptor P2Y12	BGN75O	1-Butyl-4-nitrobenzotriazole	Investigative	85909522	C10H12N4O2	220.23	CCCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1050000 nM	Non binder
T35264	Purinergic receptor P2Y12	BJW3N2	2-Hexyl-4-nitrobenzotriazole	Investigative	137642967	C12H16N4O2	248.28	CCCCCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 940000 nM	Non binder
T35264	Purinergic receptor P2Y12	BMD86N	1-Methyl-7-nitrobenzotriazole	Investigative	601138	C7H6N4O2	178.15	CN1C2=C(C=CC=C2[N+](=O)[O-])N=N1	IC50 = 1800000 nM	Non binder
T35264	Purinergic receptor P2Y12	BN8T2M	Tetrasodium;[chloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(methylamino)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-oxidophosphoryl]methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(methylamino)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphinothioyl]oxyphosphinate	Investigative	127041006	C23H29ClN10Na4O16P4S2	1017	CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=S)([O-])OP(=O)(C(P(=O)([O-])OP(=S)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)NC)O)O)Cl)[O-])O)O.[Na+].[Na+].[Na+].[Na+]	IC50 > 200000 nM	Non binder
T35264	Purinergic receptor P2Y12	BNK61A	1-Ethyl-4-nitrobenzotriazole	Investigative	137656414	C8H8N4O2	192.17	CCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1500000 nM	Non binder
T35264	Purinergic receptor P2Y12	BONS45	Adenosine 5'-[dichloro-[beta,gamma-methylene]triphosphoric acid]	Investigative	10438063	C11H16Cl2N5O12P3	574.1	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)N	IC50 = 316227.77 nM	Non binder
T35264	Purinergic receptor P2Y12	BPX73H	1H-Benzotriazole	Investigative	7220	C6H5N3	119.12	C1=CC2=NNN=C2C=C1	IC50 = 7430000 nM	Non binder
T35264	Purinergic receptor P2Y1	BQX4F5	Hexasodium;8-[[4-fluoro-3-[[3-[[3-[[2-fluoro-5-[(4,6,8-trisulfonatonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonate	Investigative	11636756	C49H28F2N6Na6O23S6	1437.1	C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(=O)NC3=C(C=CC(=C3)C(=O)NC4=C5C(=CC(=CC5=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])F)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])F.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	IC50 = 1819700.86 nM	Non binder
T35264	Purinergic receptor P2Y12	BRW52P	1-(3-Chloropropyl)-4-nitrobenzotriazole	Investigative	137652006	C9H9ClN4O2	240.64	C1=CC2=C(C(=C1)[N+](=O)[O-])N=NN2CCCCl	IC50 = 910000 nM	Non binder
T35264	Purinergic receptor P2Y12	BS2WD5	4-Nitro-2-octylbenzotriazole	Investigative	137652138	C14H20N4O2	276.33	CCCCCCCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 920000 nM	Non binder
T35264	Purinergic receptor P2Y12	BTR60W	2-Heptyl-4-nitrobenzotriazole	Investigative	137651373	C13H18N4O2	262.31	CCCCCCCN1N=C2C=CC=C(C2=N1)[N+](=O)[O-]	IC50 = 930000 nM	Non binder
T35264	Purinergic receptor P2Y12	BU4TY6	1-Methyl-4-nitrobenzotriazole	Investigative	601157	C7H6N4O2	178.15	CN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1840000 nM	Non binder
T35264	Purinergic receptor P2Y12	BU5KE2	1-Heptyl-4-nitrobenzotriazole	Investigative	137651603	C13H18N4O2	262.31	CCCCCCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 950000 nM	Non binder
T35264	Purinergic receptor P2Y12	BVHK79	4-Nitro-1-pentylbenzotriazole	Investigative	70618043	C11H14N4O2	234.25	CCCCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1070000 nM	Non binder
T35264	Purinergic receptor P2Y14	BY86BD	[[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6S)-6-(fluoromethyl)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate	Investigative	46226455	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CF)O)O)O)O)O	EC50 = 905000 nM	Non binder
T35264	Purinergic receptor P2Y12	BZLH67	1-Hexyl-4-nitrobenzotriazole	Investigative	137654461	C12H16N4O2	248.28	CCCCCCN1C2=C(C(=CC=C2)[N+](=O)[O-])N=N1	IC50 = 1040000 nM	Non binder